Evaluation of a new topical agent for burn therapy. Silver sulfadiazine (silvadene).
D000287:Administration, Topical; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000517:prevention & control; D002056:Burns / Q000188:drug therapy*; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D004361:Drug Tolerance; D006801:Humans; D009154:Mutation; D012834:Silver / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D013411:Sulfadiazine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D014946:Wound Infection / Q000517:prevention & control
D013411:Sulfadiazine; D012834:Silver